Oxprenolol, a beta-blocker, is an effective antihypertensive when administered 3 or 4 times daily. We evaluated the antihypertensive effect of oxprenololgiven twice daily (bid). The subjects were 15 ambulatory men whose standing diastolic blood pressure (BP) was at least 100 mm Hg after 3 wk of treatment with hydrochlorothiazide and oxprenolol placebo. Oxprenolol 40 mg twice daily was then substituted for the placebo. On subsequent weekly vists oxprenolol was titrated to 80 and 160 mg bid if the standing diastolic BP was greater than 90 mm Hg. BLood pressures on the last visit on placebo were compared to those on the last visit on oxprenolol. Standing BP declined from 145 +/- 4/108 +/- 1 to 130 +/- 4/98 +/- 4 on a mean dose of 256 mg of oxprenolol (p less than 0.001 syst.; p less than 0.01 diast.). Recumbent BP fell from 146 +/- 4/107 +/- 1 to 138 +/- 5/93 +/- 2 (p less than 0.06 syst.; p less than 0.01 diast.). During the final week, 13 of the 15 patients were admitted to the hospital for 24-hr monitoring of BP. The 24-hr BP readings showed a mean coefficient of variation of 6.6% recumbent and 7.2% standing. we conclude that bid oxprenolol will maintain 24 hr BP control in most patients.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt1976193325DOI Listing

Publication Analysis

Top Keywords

oxprenolol
8
standing diastolic
8
+/-
8
syst 001
8
001 diast
8
antihypertensive effectiveness
4
effectiveness oxprenolol
4
oxprenolol administered
4
daily
4
administered daily
4

Similar Publications

Magnetic particle spray mass spectrometry (MPS-MS), an innovative ambient ionization technique proposed by our research group, was employed to determine beta-blockers in human plasma samples. A dispersive solid phase extraction of atenolol, metoprolol, labetalol, propranolol, nadolol, and pindolol was carried out using magnetic molecularly imprinted polymer (M-MIP) particles that were attached to the tip of a metal probe, which was placed in the mass spectrometer inlet. A solvent (1% formic acid in methanol) was dispensed on the particles, and the Taylor cone was formed around them (in high voltage).

View Article and Find Full Text PDF

The presence of some drugs in meat samples can cause threat to human health, therefore, its analysis is highly desirable for food safety purposes. In this work, a solid-phase extraction procedure for the determination of oxprenolol, a non-selective beta-blocker, and such anabolic agents as methandienone and testosterone in beef meat samples has been developed. Extraction conditions were optimized to achieve high sensitivity and accuracy of the results.

View Article and Find Full Text PDF

Aqueous liquid chromatography with mobile phases of sodium dodecyl sulphate and ionic liquid.

J Chromatogr A

January 2023

Departament de Química Analítica, Universitat de València, c/Dr. Moliner 50, Burjassot, Spain. Electronic address:

In conventional reversed-phase liquid chromatography (RPLC) with hydro-organic solvents, basic cationic solutes yield retained, broad, asymmetric peaks, owing to their interaction with free anionic silanols in the stationary phase. RPLC mobile phases to which the anionic surfactant sodium dodecyl sulphate (SDS), or an ionic liquid (IL) are added, have been proposed as solutions, since these additives are able to block the silanol effect thus improving the chromatographic performance. With these additives, it is however necessary to increase the elution strength by adding an organic solvent, such as an alcohol or acetonitrile.

View Article and Find Full Text PDF

Background: This present study was undertaken to determine whether beta-blockers produce the cutaneous analgesic effect, comparing them with the long-acting local anesthetic bupivacaine.

Methods: Using a rat model of infiltrative cutaneous analgesia, the effect of 5 beta-blockers (oxprenolol, carteolol, butaxamine, metoprolol, and acebutolol) and bupivacaine was compared and eventually combined with epinephrine.

Results: Among 5 beta-blockers, oxprenolol exhibited the most potent and the longest duration of cutaneous analgesia.

View Article and Find Full Text PDF

The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.

J Cachexia Sarcopenia Muscle

February 2023

Departament de Bioquímica i Biomedicina Molecular, Cancer Research Group, Facultat de Biologia, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain.

Article Synopsis
  • The study tests the effectiveness of two stereoisomers of oxprenolol (S-oxprenolol and R-oxprenolol) in combating cancer cachexia using rat and mouse models, with S-oxprenolol showing superior results.
  • S-oxprenolol significantly reduced mortality and body weight loss compared to R-oxprenolol, demonstrating a clear dose-dependent effect on overall health and muscle mass in the Yoshida rat model.
  • While S-oxprenolol improved certain quality of life indicators, such as food intake and grip strength, both stereoisomers had no notable impact on heart function or structure in the doses tested.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!